Guangzhou Hexin Instrument Hits Day Low at CNY 107 Amid Price Pressure

Guangzhou Hexin Instrument Co., Ltd. experienced a notable decline today, with the stock dropping by 5.33% and reaching an intraday low of CNY 107.00. This performance contrasts with the broader market, as the China Shanghai Composite index fell by 2.06% on the same day. Over the past week, Guangzhou Hexin has shown a positive trend, gaining 4.87%, but its one-month performance reflects a decline of 10.6%. Despite a strong yearly performance of 34.82%, the company has faced challenges recently, reporting negative results for the last two consecutive quarters. The pre-tax profit for the latest quarter was recorded at CNY -22.89 million, marking a significant drop of 3,615.12%, while the net profit fell to CNY -18.74 million, a staggering decline of 20,339.17%. The company's financial metrics indicate a weak long-term fundamental strength, with a debt-to-equity ratio of 0.83 and a return on equity of -33.30%. As a mid-cap player in the pharmaceuticals and biotechnology sector, Guangzhou Hexin continues to navigate a complex financial landscape.